MSLN and ovarian adenocarcinoma: Second, Rump et al. [12] demonstrated ERC/mesothelin binds to CA125 (also named MUC16) and that the co-expression of ERC/mesothelin and CA125/MUC16 is observed in high-grade ovarian adenocarcinoma.